An immunodominant Haemophilus somnus outer membrane protein with an apparent molecular mass of 40 kDa on Western blots (immunoblots) of gradient sodium dodecyl sulfate-polyacrylamide gel electrophoresis gels was characterized because a monospecific antibody against this antigen was protective. This monospecific antibody was used for immunoaffinity purification of the antigen. The immunoaffinity-purified antigen reacted with a polyclonal antibody to the 40-kDa antigen but not with a monoclonal antibody (3G9) which reacted with the 40-kDa antigen in gradient gels. On 8 or 10% gels, the -40-kDa antigen was resolved as two bands, a 40-kDa band which reacted with the protective monospecific polyclonal antibody (p40) and a band of lower molecular mass which reacted with monoclonal antibody 3G9. The latter antigen was designated p39. Both antigens were conserved in all H. somnus isolates tested. The specific antibodies were also used to detect cross-reacting antigens in other gram-negative bacteria. Antibody to p40 reacted with proteins of 55 to 28 kDa, with the greatest intensity shown among proteins from other members of the family PasteureUlaceae. Antibody to p40 was reduced by absorption with live H. somnus or other members of the family Pasteurellaceae, so the antigen appears to be surface exposed. Antibody to p39 only cross-reacted with a broad band (38 to 40 kDa) in Haemophilus agni. Since H. agni is not a bovine pathogen and since convalescent-phase serum from H. somnus-infected animals did recognize p39, the latter may be a good immunodiagnostic antigen, if the lack of cross-reactivity with antigens in other gram-negative bacteria is confirmed with a polyclonal antibody to p39. The cross-reactivity of antiserum to p40 with antigens of members of the family Pasteurellaceae and the ability of this antiserum to protect against H. somnus pneumonia indicate that p40 may be a useful vaccine antigen for H. somnus disease and perhaps even diseases caused by other members of the family Pasteurellaceae.
Haemophilus somnus is a pleomorphic capnophilic gramnegative rod which causes several disease syndromes in cattle. The H. somnus disease complex includes thrombotic meningoencephalitis, pneumonia, laryngitis, tracheitis, septicemia, reproductive failure, arthritis, and myocarditis (2, 8, 11, 23, 24, 36) . The incidence of meningoencephalitis appears to be decreasing, and the incidence of other sequelae of septicemia or respiratory disease appears to be increasing. Asymptomatic carriers are also common. The normal vagina or prepuce is considered to be the natural habitat of H. somnus, although respiratory carriers have been detected as well (12, 13) . It is not clear whether the lack of clinical signs in carriers is due to a difference in host response between carriers and diseased animals or to a difference in virulence between isolates. At least in some cases, the carrier isolates were shown to lack virulence factors (10, 42) or to be less virulent than isolates from diseased animals (19, 24) .
Control of this disease complex is a problem. Although the organism is usually susceptible to most antibiotics, resistant strains are emerging. Even when the strains are susceptible, difficulties in diagnosis and the refractory nature of some of the septicemic syndromes make treatment unsatisfactory (23, 24) . Immunization is a more attractive approach to control. Commercially available killed whole-cell vaccines have been shown to be effective against thrombotic meningoencephalitis (39, 40) , but vaccine efficacy in other forms of H. somnus disease has been less well proven (20, 22, 24, 30, 35) . A subunit vaccine composed of only the most protective antigen(s) may give greater protection because of the optimum concentration of the antigen(s) in the absence of competing nonprotective antigens. With this approach in mind, we characterized the specificity of convalescent-phase serum which was shown to be passively protective (15) . The immunodominant antigen was a 40-kDa outer membrane protein (OMP) (9, 14, 15) exposed at the surface (9, 15) and accessible to an antibody. Therefore, an essentially monospecific bovine polyclonal antibody to the 40-kDa OMP was produced and shown to passively protect calves against experimental H. somnus pneumonia (15) . Since the 40-kDa protein was also recognized as the most intense band in Western blots (immunoblots) with convalescent-phase serum from 17 of 17 animals in an experimental abortion study (9) , the antigen is a good candidate for a subunit vaccine. However, this band occasionally appeared as a doublet in Western blots with convalescent-phase serum. Thus, it was unclear whether one or two antigens were involved. In this study, we report the characterization and immunoaffinity purification of this immunodominant OMP of H. somnus as a candidate for a subunit vaccine. We also show that the immunodominant 40-kDa OMP is antigenically distinct from a 39-kDa OMP of H. somnus, even though they run together on a gradient gel. (9, 27 ) and gramnegative bacteria (27) as those used in our previous studies. The H. somnus isolates included five from TME (43826, 0289, 8025, 91-1, and 109B), five from pneumonia (1542, 2336, 3581, 3415-2, and 1297), four from reproductive failure (1030, 2069, 570, and B83-145), four from vaginal carriers (41VC, 202V, 208V, and 221V), and four from preputial carriers (iP, 24P, 127P, and 129Pt). In some studies, we also used isolate 649, because we previously showed it to cause abortion (9, 43 15 ,000 lb/in2. Membranes were extracted with 2% (wt/vol) N-laurylsarcosine (Sigma) as previously described (27) . The detergent-insoluble pellet was suspended in N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid buffer (pH 7.4), and total protein was determined by the Bradford method (3) (protein assay kit from Bio-Rad Laboratories, Richmond, Calif.).
Antibodies. (i) Convalescent-phase antiserum. Two 12-week-old male holstein calves (E5 and E7) were inoculated intrabronchially with 107 CFU of H. somnus 2336 as previously described (14, 16, 17) . Both calves were febrile, depressed, and anorectic, with coughing for 3 days (14, 17) , but recovered, except for sporadic coughing thereafter. H. somnus was recovered from weekly bronchial lavage fluid samples through week 5 (17) . Convalescent-phase serum used in this study was collected at week 6, when high serum immunoglobulin GI (IgGl) and IgG2 titers were detected by an enzyme-linked immunosorbent assay (ELISA) with whole H. somnus as the antigen (14, 17, 43) . The sera from the two calves had essentially the same reactivities in Western blots. Convalescent-phase serum was also collected from a cow (P3) 5 weeks after intrabronchial challenge with H. somnus 649 (9) . The latter convalescent-phase serum was used for absorption studies because it contained less antibody to the 40-kDa OMP, so reactivity could be more easily removed by absorption with whole live bacteria. Also, the use of convalescent-phase sera from two different disease syndromes caused by H. somnus provides more information about the diagnostic potential of the antigens recognized.
(ii) Antiserum to the 40-kDa OMP. A 16-week-old male holstein calf (R85/86) was immunized with gel-purified 40-kDa OMP as previously described (15) . In brief, 200 ,ug of the N-lauroylsarcosine-insoluble OMP-enriched fraction was solubilized in sodium dodecyl sulfate (SDS) sample buffer and loaded on a preparative 10% SDS-polyacrylamide gel electrophoresis (PAGE) slab gel. After electrophoresis and light staining with Coomassie brilliant blue, a 1-mm-wide strip of gel was cut out immediately below the 41-kDa major OMP, which is not recognized by convalescent-phase serum (9, 14) . The strips from two gels were pulverized in 2 ml of PBS with a mortar and pestle, and the slurry was emulsified with 2 ml of Freund's incomplete adjuvant for subcutaneous immunization. A calf was immunized on weeks 0, 4, 6, 8, 10, 12, and 16. Sera collected on day 0 and 7 days after the last immunization were used in this study.
(iii) MAbs. Hybridomas were prepared as previously described (26) by immunization of BALB/c mice twice intraperitoneally with 5 x 107 live H. somnus cells. Three days after the second immunization, spleen cells were fused with P3U1 cells. Hybridoma cells were screened for monoclonal antibody (MAb) production by an ELISA as previously described (43) with whole H. somnus as the antigen and the cells of interest cloned by limiting dilution. Positive supernatants were further characterized by Western blotting.
Protein profiles and Western blotting. As before (9, 14, 27) , SDS-PAGE of whole cells, detergent-extracted OMP preparations, or purified 40-kDa OMP was done as described by Laemmli (28) with 7.5 to 17.5% polyacrylamide gradient gels and reducing conditions (9) , unless otherwise noted. In most instances, SDS-PAGE was followed by Western blotting, for which SDS-PAGE gels were equilibrated in Tris-glycine transfer buffer (41) 
RESULTS
The immunodominant 40-kDa OMP of H. somnus usually appeared as a single band in Western blots of gradient SDS-PAGE gels probed with convalescent-phase serum, but occasionally a doublet was detected (Fig. 1) . Although the doublet was seen with strain 649 but not with strain 2336 in Fig. 1 , the presence of a doublet was inconsistent and was not restricted to particular strains. To characterize this OMP antigen further and to provide antigen for later studies of active immunization, we immunoaffinity purified the protein with a bovine polyclonal antibody specific for the 40-kDa OMP (antibody to p40). This antiserum was previously shown to be monospecific and to passively protect calves against H. somnus pneumonia (15) . Preliminary experiments to determine optimal extraction procedures for p40 indicated that abundant p40 (as well as other proteins, except for p78) was obtained after incubation of bacteria for 2 h in 0.2% sodium deoxycholate in 150 mM NaCl-50 mM Tris-10 mM EDTA (pH 7.8). Results of detergent extractions were similar, regardless of incubation temperature (4, 22, or 37°C), so all extractions were done at 4°C. Immunoaffinity purification with the antibody to p40 coupled to cyanogen bromide-activated Sepharose 4B separated p40 from the other antigens detected with convalescent-phase serum in Western blots of whole-cell lysates or deoxycholate extracts of surface antigens (Fig. 2) .
This immunoaffinity-purified 40-kDa antigen was used to determine whether members of the p40 doublet (Fig. 1 ) could be separated. Solubilized H. somnus cells were electrophoresed in an 8% SDS-PAGE gel, and the Western blot was probed with antibodies specific for the 39-or 40-kDa antigen. This procedure resulted in definite separation of the 39-and 40-kDa OMPs (Fig. 3) . In a parallel strip, convalescent- phase serum detected both antigens (Fig. 3) . The nonidentity of these two OMPs was confirmed by comparing immunoaffinity-purified 40-kDa antigen, sodium deoxycholate extracts, and whole cells of H. somnus 2336 electrophoresed in 8% SDS-polyacrylamide gels and blotted to nitrocellulose. This blot was cut through the middle of prestained Rainbow molecular weight markers (Amersham Corp., Arlington Heights, Ill.) so that both halves could be accurately realigned after reaction of one half with convalescent-phase serum (E7) and the other half with MAb 3G9. A single band detected by MAb 3G9 corresponded to the lower band in the doublet detected by convalescent-phase serum (Fig. 2) . The upper band corresponded to immunoaffinity-purified p40. Thus, bovine antiserum to p40 reacts with the H. somnus 40-kDa OMP, whereas MAb 3G9 reacts with a 39-kDa OMP.
Both were present in the sodium deoxycholate extract of live H. somnus 2336 (Fig. 2) . Antibody to the 40-kDa OMP reacted with the immunoaffinity-purified 40-kDa OMP but, in a separate experiment, MAb 3G9 did not (Western blot not shown).
If an antigen is to be considered as an effective vaccine, it should be conserved in all pathogenic and potentially pathogenic isolates of the organism. Western blots of H. somnus isolates from both diseased and carrier cattle showed that 22 of 22 isolates had the 40-kDa antigen and that 14 of 14 had the 39-kDa antigen. The latter 14 isolates included the 5 isolates from thrombotic meningoencephalitis, 5 isolates from pneumonia, and 4 vaginal isolates which were reacted with antiserum to p40 and listed in Materials and Methods. The apparent molecular mass of p40 varied among isolates by approximately 2 kDa, whereas with p39, size variation was not detected.
The close relationship among the members of the family Pasteurellaceae prompted an examination of the crossreactivity of these two antigens with antigens of the members of these species as well as other gram-negative bacteria. Western blots of a bank of gram-negative bacteria did not react with preimmunization serum, but several species showed proteins cross-reactive with p40 ( Table 1 ). The molecular mass of the recognized major protein varied from 55 to 28 kDa ( Table 1 ). The greatest intensity of reaction was seen with the members of the family Pasteurellaceae (Fig.  4) . Thus, we attempted to determine whether the crossreactive antigen was located on the surface of these organisms. Convalescent-phase serum P3 was absorbed with live log-phase cells of each isolate for 3 h at 4°C. Absorption with the homologous H. somnus isolate removed reactivity with both the 76-and the 40-kDa antigens, whereas absorption with Pasteurella haemolytica removed reactivity with only the 40-kDa antigen (Fig. 5) . The reactivity with this 40-kDa antigen was reduced by absorption with Pasteurella multocida and Actinobacillus equuli but was not removed entirely.
Since P. haemolytica, P. multocida, and H. somnus are the major bacteriologic etiologic agents of the bovine respiratory disease complex, several clinical isolates of each of these species were analyzed by Western blotting with the antibody to p40. Each isolate (22 of 22 H. somnus, 11 of 11 P. haemolytica, and 12 of 12 P. multocida isolates) had a conserved protein which reacted with the antiserum. The relative molecular masses of the P. multocida (-55 kDa) and P. haemolytica (-50 kDa) cross-reactive antigens varied minimally within each species. However, 6 of 12 isolates of P. haemolytica had a second cross-reactive antigen at -97 kDa. All isolates were also tested against preimmunization serum collected from the calf (R86/85) immunized with gel-purified 40-kDa OMP (15) . No appreciable reactivity with the preimmunization serum was detected, except for a band at approximately 170 kDa with a few isolates of P. multocida. Since this band was detected with both pre-and postimmunization sera, it is not listed as an antigen crossreactive with p40.
Western blots of a bank of gram-negative bacteria reacted with monoclonal antibody 3G9 demonstrated a cross-reactive protein only in H. agni (Table 1 ). The band recognized in H. agni by MAb 3G9 appeared as a broad doublet which extended above and below the 39-kDa band of H. somnus.
DISCUSSION
In this study, we characterized two OMP antigens of H. somnus which usually appeared as one band of approximately 40 kDa on gradient gels. In a previous study, we prepared an antibody to the 40-kDa antigen cut from a 10% SDS-PAGE gel and showed that the polyclonal antibody passively protected calves against experimental H. somnus pneumonia (15 (2, 38) ; therefore, the cross-reactivity between H. somnus and H. agni should not lead to confusion in diagnostic assays. If similar results are obtained with a polyclonal antibody to p39, the lack of cross-reactivity of p39 with antigens of other gramnegative bacteria indicates that false-positives should not occur because of antigenic cross-reactions in an immunodiagnostic test based on p39. The conservation of p39 among all H. somnus isolates tested, the potential lack of crossreactivity with other bovine normal flora or pathogens, and the reactivity of p39 with the convalescent-phase sera used in this study highlight the potential utility of p39 as a diagnostic antigen.
The antibody to the 40-kDa OMP, on the other hand, was very cross-reactive. The most intense cross-reactivity, with species within the family Pasteurellaceae, reflects the close genetic relationships among this group (4, 18, 24, 38) . Differences in the molecular sizes of cross-reactive antigens in different isolates are consistent with their classification into different genera and species. The observations that the antibody against p40 of H. somnus reacted with a 47-kDa antigen of H. agni but that MAb 3G9 reacted with antigens of similar molecular masses in both H. somnus and H. agni provide further evidence that p40 and p39 are unrelated in H. somnus. The cross-reactivity of the antibody to p40 with proteins of other gram-negative bacteria indicates that many false-positive reactions may occur in immunodiagnostic tests based on this antigen. However, cross-reactivity with proteins of other members of the family Pasteurellaceae may be an advantage in subunit vaccines. The cross-reactive antigens appear to be surface exposed in P. haemolytica and perhaps P. multocida and Actinobacillus spp., as determined by absorption studies. This result agrees with that of our previously reported absorption study (9) : a decrease in antibody to the 40-kDa antigen after absorption with P. haemolytica. However, the convalescent-phase serum (P3) used in the present study had less antibody to p40 than did the serum used in our previous study (9) , so more complete absorption was seen in the present study. Furthermore, others have shown that the antibody response to a P. haemolytica 49-kDa surface antigen is significantly correlated with low lesion scores after vaccination and challenge (34) . It is likely that the 49-kDa antigen reported by Mosier et al. (34) corresponds to our 50-kDa cross-reactive antigen, since both are surface exposed and recognized by bovine convalescent-phase serum. Therefore, a subunit vaccine composed of the H. somnus 40-kDa OMP may be protective against bovine pasteurellosis as well as against the H. somnus disease complex. Others have shown that, although the leukotoxin of P. haemolytica is an important virulence factor (29) , somatic antigens are also required for protection against pasteurellosis (37) . In fact, somatic antigens may be all that is required for protection if oil adjuvants are used (5, 6, 7) . In another study, an H. somnus bacterin was shown to decrease the number of days of treatment needed for bovine respiratory disease, even though P. haemolytica was the only pathogen isolated from pretreatment nasal swabs of sick cattle (33) . This result suggests that cross-reactive antigens of H. somnus may have some protective activity against pasteurellosis. Since the antibody to p40 used for immunoaffinity purification in this study was the same antibody preparation that we previously showed to passively protect against H. somnus pneumonia (15) , the immunoaffinity-purified antigen may be a useful component in a vaccine against the major bacterial etiologic agents of the bovine respiratory disease complex, P. haemolytica, P. multocida, and H. somnus.
